Bluejay Diagnostics Inc BJDX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $5.30
- Day Range
- $4.82–5.91
- 52-Week Range
- $1.64–16.64
- Bid/Ask
- $0.00 / $0.00
- Shares Outstanding
- 1.03M
- Market Cap
- $4.97M
- Volume/Avg
- 717,957 / 1M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 6
- Website
- https://www.bluejaydx.com
Valuation
|
Metric
|
BJDX
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.22 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
BJDX
|
|---|---|
Quick Ratio | 2.61 |
Current Ratio | 2.81 |
Interest Coverage | — |
Quick Ratio
BJDX
Profitability
|
Metric
|
BJDX
|
|---|---|
Return on Assets (Normalized) | −117.87% |
Return on Equity (Normalized) | −150.06% |
Return on Invested Capital (Normalized) | −147.54% |
Return on Assets
BJDX
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Pmxtylwf | Wjkqnkp | $159B | |||
| Stryker Corp
SYK
| Fglglntb | Rrd | $117B | |||
| Medtronic PLC
MDT
| Ppyfrttzz | Qwlvgk | $105B | |||
| Boston Scientific Corp
BSX
| Dghrxxyx | Vxwxxcg | $72B | |||
| Edwards Lifesciences Corp
EW
| Xszvffckm | Bbxtrcf | $49B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| Crsqmxfr | Btrh | $29B | |||
| DexCom Inc
DXCM
| Kxswsvws | Fvwnyxw | $28B | |||
| Koninklijke Philips NV ADR
PHG
| Cfb | Gfqn | $25B | |||
| Steris PLC
STE
| Yvhzbyqt | Qthvsf | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| Hslcmwgmd | Bkwr | $17B |
United States